Sanara MedTech (SMTI) Long-Term Deferred Tax (2012 - 2020)

Sanara MedTech (SMTI) posted Long-Term Deferred Tax of $13.5 million for Q4 2020, up 51.11% on a QoQ basis from $8.9 million in Q4 2019, and up 51.11% year-over-year from $8.9 million in Q1 2020.

Sanara MedTech (SMTI) Long-Term Deferred Tax (2012 - 2020) Analysis & Trends

Sanara MedTech's Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $13.5 million for Q4 2020.

  • Quarterly Long-Term Deferred Tax rose 51.11% year-over-year to $13.5 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $13.5 million (up 51.11% YoY) and the FY2020 annual result came in at $13.5 million, up 51.11% from the prior year.
  • Long-Term Deferred Tax was $13.5 million for Q4 2020 at Sanara MedTech, up from $8.9 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $13.5 million in Q4 2020 and bottomed at $8.9 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Sanara MedTech 233.71 Mn 220.11 Mn 25.87 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 13.50 Mn
Dec 31, 2019 8.93 Mn
Dec 31, 2015 11.78 Mn
Dec 31, 2012 2.89 Mn